Why the study?
Does colchicine improve outcomes in patients with cardiovascular diseases such as postoperative atrial fibrillation and pericarditis?
Does colchicine improve outcomes in patients with cardiovascular diseases such as postoperative atrial fibrillation and pericarditis?
This review summarizes the evidence and provides recommendations for the use of colchicine in cardiovascular conditions such as postoperative atrial fibrillation and pericarditis.
Answers are grounded in this paper and cite their sources.
Colchicine may be considered for postoperative AF and pericarditis; leaves open need for larger RCTs to guide practice.
Colchicine is one of the oldest medications still in use today and is commonly used for the treatment of gout and familial Mediterranean fever. Its anti-inflammatory properties have raised the question of its utility in managing several cardiovascular diseases, including postoperative atrial fibrillation and pericarditis. This article will review the evidence for colchicine in these conditions and provide recommendations for use.
No takes yet. Share an insight, caveat, or question.
Campbell et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: